PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 102 filers reported holding PROVENTION BIO INC in Q3 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,097 | +245.4% | 253 | +51.5% | 0.00% | – |
| Q4 2022 | $1,765 | -85.3% | 167 | -94.4% | 0.00% | – |
| Q2 2022 | $12,000 | -53.8% | 3,000 | -14.8% | 0.00% | – |
| Q1 2022 | $26,000 | +30.0% | 3,521 | 0.0% | 0.00% | – |
| Q4 2021 | $20,000 | -51.2% | 3,521 | -45.4% | 0.00% | – |
| Q3 2021 | $41,000 | -22.6% | 6,452 | +3.4% | 0.00% | – |
| Q2 2021 | $53,000 | +1.9% | 6,239 | +24.8% | 0.00% | – |
| Q1 2021 | $52,000 | +2.0% | 5,000 | +66.7% | 0.00% | – |
| Q4 2020 | $51,000 | +34.2% | 3,000 | 0.0% | 0.00% | – |
| Q3 2020 | $38,000 | -9.5% | 3,000 | 0.0% | 0.00% | – |
| Q2 2020 | $42,000 | +50.0% | 3,000 | 0.0% | 0.00% | – |
| Q1 2020 | $28,000 | -37.8% | 3,000 | 0.0% | 0.00% | – |
| Q4 2019 | $45,000 | +125.0% | 3,000 | 0.0% | 0.00% | – |
| Q3 2019 | $20,000 | -44.4% | 3,000 | 0.0% | 0.00% | – |
| Q2 2019 | $36,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |